Education
About Us
Working with TipRanks
Follow Us
RxSight (RXST)
NASDAQ:RXST
Total Valuation
RxSight has a market cap or net worth of $317.34M. The enterprise value is $308.43M.
Market Cap$317.34M
Enterprise Value$308.43M
Share Statistics
RxSight has 41,266,335 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding41,266,335
Owned by Insiders5.60%
Owned by Institutions23.11%
Financial Efficiency
RxSight’s return on equity (ROE) is -0.14 and return on invested capital (ROIC) is -16.81%.
Return on Equity (ROE)-0.14
Return on Assets (ROA)-0.12
Return on Invested Capital (ROIC)-16.81%
Return on Capital Employed (ROCE)-0.17
Revenue Per Employee270.03K
Profits Per Employee0.00
Employee Count498
Asset Turnover0.43
Inventory Turnover1.00
Valuation Ratios
The current PE Ratio of RxSight is ―. RxSight’s PEG ratio is -0.33.
PE Ratio―
PS Ratio3.19
PB Ratio1.56
Price to Fair Value1.56
Price to FCF-22.18
Price to Operating Cash Flow0.00
PEG Ratio-0.33
Income Statement
In the last 12 months, RxSight had revenue of 134.48M and earned -38.94M in profits. Earnings per share was -0.95.
Revenue134.48M
Gross Profit103.01M
Operating Income-48.19M
Pretax Income-38.88M
Net Income-38.94M
EBITDA-39.62M
Earnings Per Share (EPS)-0.95
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
RxSight pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.24
52-Week Price Change-68.94%
50-Day Moving Average9.09
200-Day Moving Average10.03
Relative Strength Index (RSI)38.65
Average Volume (3m)975.84K
Important Dates
RxSight upcoming earnings date is May 12, 2026, After Close (Confirmed).
Last Earnings DateFeb 25, 2026
Next Earnings DateMay 12, 2026
Ex-Dividend Date―
Financial Position
RxSight as a current ratio of 10.95, with Debt / Equity ratio of 4.00%
Current Ratio10.95
Quick Ratio9.75
Debt to Market Cap0.03
Net Debt to EBITDA0.22
Interest Coverage Ratio-1.20K
Taxes
In the past 12 months, RxSight has paid 66.00K in taxes.
Income Tax66.00K
Effective Tax Rate>-0.01
Enterprise Valuation
RxSight EV to EBITDA ratio is -10.60, with an EV/FCF ratio of -21.72.
EV to Sales3.12
EV to EBITDA-10.60
EV to Free Cash Flow-21.72
EV to Operating Cash Flow-27.09
Balance Sheet
RxSight has $228.13M in cash and marketable securities with $11.04M in debt, giving a net cash position of $217.09M billion.
Cash & Marketable Securities$228.13M
Total Debt$11.04M
Net Cash$217.09M
Net Cash Per Share$5.26
Tangible Book Value Per Share$6.70
Margins
Gross margin is 76.60%, with operating margin of -35.84%, and net profit margin of -28.96%.
Gross Margin76.60%
Operating Margin-35.84%
Pretax Margin-28.91%
Net Profit Margin-28.96%
EBITDA Margin-29.46%
EBIT Margin-28.88%
Analyst Forecast
The average price target for RxSight is $10.33, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$10.33
Price Target Upside34.33% Upside
Analyst ConsensusHold
Analyst Count9
Revenue Growth Forecast10.75%
EPS Growth Forecast-7.15%